Neuroscience Market

Significance of Neuroscience Buoyant With High Prevalence of Brain and Nervous System Conditions

The Neuroscience Market is valued at USD 43.2 Bn in 2026 and is projected to reach USD 58.1 Bn,  growing at a CAGR of 4.30% by 2033.Neuroscience continues to be one of the most sought-after areas of research. With the rising prevalence of neurological disorders worldwide, the need for superior patient outcomes is also mounting, thereby pushing the expanse of the global neuroscience market. Neuroscience research is advancing at a rapid pace, making exciting progress on a wide variety of issues that range from the slowing of degenerative diseases such as amyotrophic lateral sclerosis (ALS), Huntington’s disease, and Parkinson’s, to discoveries on how the brain develops in early childhood.

There are more than 1,000 (heterogeneous group of) disorders of the brain, and nervous system, including -

• Intellectual and developmental disabilities such as Down syndrome, and Fragile X syndrome
• Behavioural disorders such as attention deficit/hyperactivity disorder, and autism spectrum disorders
• Learning disabilities and reading disorders - dyslexia
• Mental health problems such as schizophrenia, obsessive-compulsive disorder, and addiction
• Degenerative diseases such as Alzheimer’s, Parkinson’s, and Niemann-Pick disease
• Musculoskeletal disorders such as muscular dystrophy, and stroke
• Structural defects, such as neural tube defects, which include spina bifida, hydrocephaly, and myelomeningocele
• Injuries, including traumatic brain injury, and spinal cord injury
• Cancers, including brain tumours such as paragangliomas
• Epilepsy, seizures, and stroke

Critical Need for Effective Therapeutics Fuels Neuroscience Market Growth

The brain is the pivotal hub of our central nervous system. A complex, sophisticated system, its nervous tendrils permeate every inch of our bodies, ultimately regulating, and coordinating the body's basic functions, and activities. Due to its vast structural, and functional intricacy, neuroscientists have the daunting task of trying to understand how all these billions of neurons in the brain, and nervous system work. The aetiology of these diseases is still not completely understood, and a majority of medication only treats the symptoms. There is an urgent need to develop novel therapies for better outcomes. Biological assays, including aggregation, cytotoxicity, and signalling assays are vital in aiding researchers to better comprehend the underlying mechanisms of these conditions in addition to discovering promising treatments in the primary stages of drug development.

Technology Is Facelifting Modern Neuroscience to Enable Better Understanding of Brain

Neuroscience is panacea for curing diseases. Although there has been incredible progress, there is still much left to discover, giving the global neuroscience market a vast potential.

New techniques such as special electrodes that can touch the surface of cells, electroceuticals to regulate nerve signals, neuro-regeneration, genomic sequencing, and genome editing, optical imaging – (diffuse optical imaging (DOI), functional ultrasound brain imaging, from Iconeus, is the next frontier in pre-clinical neuroscience), human brain scanning machines, and silicon chips containing artificial brain circuits, transcranial magnetic stimulation (TMS), liposomal-based strategies, light therapy consisting of controlled exposure to natural daylight or artificial light of specific wavelengths, and WuXi AppTec are all changing the face of the global neuroscience market. With life expectancies climbing worldwide, treating health at the level of the brain will become increasingly important to global human wellbeing.

Neuroscience Market Mental Health Problems Exert an Enormous Social and Economic Burden Demanding

According to the Global Burden of Disease study, neuropsychiatric disorders attribute for over 10% of the global burden of disease. As per The UN General Assembly Report of December, 2017, neurological disorders are the leading cause of disability, and the second leading cause of death worldwide. The World Health Organization (WHO) assesses that 10.8 million people die every year due to neurological disorders.

Global Neuroscience Market Set for Notable Growth as Research Efforts Firm up and Investments Flood in

There has been a rapid rise in total neuroscience research, with China becoming a major player pressuring the US into an arms race of the brain. Investment initiatives around the globe such as Obama’s Brain Initiative, as well as scores of research pledges on the horizon that outpace any other scientific domain are also heavily contributing towards the growth of the neuroscience market.

The International Brain Initiative (IBI) - Europe, Japan, Korea, Australia, and the United States coalition - to coordinate efforts across existing and emerging national and regional brain initiatives, develop, and recognize ethical considerations that may arise from advances in neuroscience, neurotechnology, and Artificial Intelligence (AI)

The Global Engagement Initiative led by the International Brain Research Organization (IBRO)

International Brain Research Foundation Inc. (IBRF), Society for Neuroscience (SfN), Federation of European Neuroscience Societies (FENS), International Society for Neurochemistry (ISN) - platforms for advocacy, support and collaboration, outreach and awareness activities for a broader and more inclusive reach

BrainFacts.org - a public information initiative

Global Neuroscience Market: Key Players

 

• Eli Lilly and Company
• Pfizer Inc.
• Novartis AG
• Roche Holding AG
• Biogen Inc.
• AbbVie Inc.
• Johnson & Johnson
• Merck & Co., Inc.
• AstraZeneca plc
• GlaxoSmithKline plc (GSK)
• Bayer AG
• Boston Scientific Corporation
• Medtronic plc
• Abbott Laboratories
• Siemens Healthineers AG

Global Neuroscience Market is Segmented as Follows:

By Component

• Instruments
• Consumables
• Software & Services

By Technology

• Brain Imaging
• Neuro-Microscopy
• Stereotaxic Surgeries
• Neuro-Proteomic Analysis
• Neuro-Cellular Manipulation
• Others

By End-user

• Hospitals
• Diagnostic laboratories
• Research and Academic Institute

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa